Aardvark Adventures Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Aardvark Adventures

DAVE 207.00

-1.5%

Dec 5 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ~digs who wrote (5037)	6/20/2008 12:09:41 PM
From: Saulamanca	Read Replies (1) of 7944

RXII RXi Pharmaceuticals Low volume play but can move a couple of dollars quick when it wants to. RXi Pharmaceuticals Corporation, a discovery-stage biopharmaceutical company, focuses on developing and commercializing proprietary therapeutics based on RNA interference (RNAi) for the treatment of human diseases. It intends to identify lead compounds and advance towards pre-clinical and clinical development programs in the various therapeutic areas, including neurology; metabolic diseases, such as obesity and obesity-related type 2 diabetes; and oncology.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next